Key result
Tissue factor pathway inhibitor regulates tissue factor-induced coagulation to limit thrombus formation to injury sites.
Answers are grounded in this paper and cite their sources.
Under normal conditions the blood circulates freely within the confines of the vascular system, carrying oxygen, nutrients, and hormonal information around the body and removing metabolic waste. If blood gains access to extravascular sites, or the vasculature becomes pathologically challenged, hemostasis may be activated. This process is finely regulated by positive and negative feedback loops that modulate fibrin clot formation. Blood coagulation revolves around the activation and assembly of the components of the prothrombinase complex, which converts the inactive zymogen, prothrombin, into its active form, thrombin. This serine protease catalyzes the conversion of fibrinogen to fibrin, the structural scaffold that stabilizes platelet aggregates at sites of vascular injury. The extent of the hemostatic response is controlled by the action of inhibitory pathways, which ensure that thrombin activity and the spread of the hemostatic plug is limited to the site of vessel damage. This review article focuses on the major physiological regulator of tissue factor-induced coagulation, tissue factor pathway inhibitor, its expression, anticoagulant function, and its role in normal hemostasis.
No takes yet. Share an insight, caveat, or question.
Crawley et al. (2007) conducted a review in Hemostasis and blood coagulation. Tissue factor pathway inhibitor was evaluated. Tissue factor pathway inhibitor acts as the major physiological regulator of tissue factor-induced coagulation, controlling thrombin activity and limiting the hemostatic plug to vascular injury sites.
Synapse has enriched 10 related papers. Consider them for comparative context: